Nature Medicine
- 12, 1390 - 1396 (2006)
Published online: 19 November 2006; | doi:10.1038/nm1485
Activation of  2-adrenergic receptor stimulates  -secretase activity and accelerates amyloid plaque formationYanxiang Ni1, 3, Xiaohui Zhao1, 3, Guobin Bao1, Lin Zou1, Lin Teng1, Zhu Wang1, Min Song2, Jiaxiang Xiong2, Yun Bai2 & Gang Pei11
Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Graduate School of the Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, China. 2
Department of Medical Genetics, Third Military Medical University, 30 Gao Tan Yan, Chongqing 400038, China. 3
These authors contributed equally to this work.
Correspondence should be addressed to Gang Pei gpei@sibs.ac.cn Amyloid plaque is the hallmark and primary cause of Alzheimer disease. Mutations of presenilin-1, the  -secretase catalytic subunit, can affect amyloid- (A) production and Alzheimer disease pathogenesis. However, it is largely unknown whether and how -secretase activity and amyloid plaque formation are regulated by environmental factors such as stress, which is mediated by receptors including 2-adrenergic receptor (2-AR). Here we report that activation of 2-AR enhanced -secretase activity and thus A production. This enhancement involved the association of 2-AR with presenilin-1 and required agonist-induced endocytosis of 2-AR and subsequent trafficking of -secretase to late endosomes and lysosomes, where A production was elevated. Similar effects were observed after activation of  -opioid receptor. Furthermore, chronic treatment with 2-AR agonists increased cerebral amyloid plaques in an Alzheimer disease mouse model. Thus, 2-AR activation can stimulate -secretase activity and amyloid plaque formation, which suggests that abnormal activation of 2-AR might contribute to A accumulation in Alzheimer disease pathogenesis.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
